The World Health Organization (WHO) has validated Eritrea’s elimination of trachoma as a public health problem, making it the 11th country in WHO’s African Region and the 34th globally to reach this major milestone.
“I congratulate the Government and people of Eritrea on this historic achievement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “After two decades of determined effort, Eritrea has consigned trachoma as a public health problem to history. This is a victory for the communities most affected by this devastating disease, and a powerful example of what sustained national commitment can achieve.”
In Eritrea, many people live in remote rural areas where access to health care and clean water and sanitation can be limited, creating conditions that facilitate the transmission of trachoma. Following baseline surveys conducted in different parts of the country between 2006 and 2020, Eritrea progressively implemented WHO’s recommended SAFE strategy in communities where interventions were needed. The strategy comprises surgery for trachomatous trichiasis, antibiotics to clear infection, facial cleanliness to reduce transmission, and environmental improvement, particularly improved access to water and sanitation.
“I congratulate Eritrea on this historic public health milestone. It shows what is possible through sustained political commitment, community leadership and strong partnerships,” said Dr Mohamed Janabi. “Eritrea’s achievement brings us closer to a world free from the suffering caused by neglected tropical diseases and sends a strong message of hope to other African countries working towards trachoma elimination. With determination and collective action, we can protect the health and well-being of communities and leave no one behind.”
Eritrea’s programme adopted a community-led sanitation approach that helped achieve significant public health gains with limited external funding. Health workers used digital tools for data collection and mapping to identify affected communities and target resources, including in hard-to-reach areas. The country surveyed all 58 sub-zobas (second-level administrative areas) and scaled up interventions wherever trachoma was endemic. The antibiotics distributed were predominantly oral azithromycin, donated by Pfizer Inc. through the International Trachoma Initiative. Eritrea has also established systems to identify and manage new trichiasis cases and will continue surveillance following validation.
“This success belongs first and foremost to the people of Eritrea. The elimination of trachoma as a public health problem is the result of strong national leadership and ownership, and collaboration between communities, the Ministry of Health, the Fred Hollow’s Foundation, development partners and health workers across the country,” said Dr Mary Stephen, WHO Representative to Eritrea. “WHO is proud to have supported Eritrea throughout this journey and will continue to work closely with the Government and partners to sustain these gains.”